Special clinical interest in MR Linac, Stereotactic radiotherapy, Brain and Spine tumours, upper gastrointestinal tumours, skin cancer and benign conditions
Farshad is a radiation oncologist who has a passion to achieve the best patient outcomes through transparent communication and utilization of the best evidence and technology.
He completed his specialist training in 2020 at Liverpool and Campbelltown Hospitals with a year of clinical experience at the Canberra hospital.
He subsequently undertook a clinical/research fellowship at St George Hospital, NSW, focusing on genitourinary and gastrointestinal malignancies with special interest in brachytherapy and stereotactic techniques.
Farshad’s clinical interests are upper GI, neuro-oncology, skin, MR guided and stereotactic radiotherapy. He has also an interest in medical innovations and technology as well as quality assurance.
Farshad is an active clinical researcher and is also involved with clinical education. He is a conjoint lecturer at university of New South Wales (UNSW) and he has peer reviewed articles for Journal of Medical Imaging and Radiation Oncology.
- Best quality research, faculty of radiation oncology FRANZCR 2020
- Trans-Tasman Radiation Oncology Group (TROG),
- European Society Radiation Oncology (ESTRO),
- Australian Brachytherapy Group (ABG),
- Stereotactic Interest Group Australasia (SIGA)
- Evaluation of the introduction of a “traffic light protocol” for dose volume histogram constraints of organs at risk (OAR) in definitive radiotherapy at Liverpool and Macarthur Cancer Therapy Centres, Kasraei F, et.al. March 2020, Journal of Medical Imaging and radiation oncology, doi.org/10.1111/1754-9485.13023
- Merkel Cell Carcinoma: When Does Size Matter for Radiotherapy? Kasraei F, Roach M, Lee M, (December 2015) Cureus 7(12): e443. doi:10.7759/cureus.443